Did you know you can place an order for Ozempic sourced from a reliable source in Singapore? While Canadian inventory is limited we offer our customers alternate solutions. Speak to a live agent today.

Save 10% off on your first order with coupon code: FIRST10OFF

weighing scale for weight loss ZepBound

Determining a healthy weight can be challenging for many people, influenced by public health campaigns that highlight weight as a risk factor for various health issues. However, weight alone doesn’t always reflect overall health, and achieving weight loss can be difficult, particularly when factors contributing to weight gain are beyond one’s control. This difficulty has led to the increased use of medications such as Ozempic to aid weight loss.

Approximately 8% of women and 2% of men will experience a diagnosed eating disorder at some point, with many more possibly affected without formal diagnosis. As medications like Ozempic gain popularity, concerns arise regarding their impact on individuals with eating disorders.

How do medications like Ozempic facilitate weight loss?

girl weight loss in ZepBound

Ozempic, a GLP-1 agonist originally designed for Type 2 diabetes treatment, has been found to promote weight loss as well.

Weight loss medications have a long history, with some withdrawn due to significant health risks. Currently, nine medications are FDA-approved for medically necessary weight loss, with GLP-1 agonists recognized as particularly effective.

Semaglutide, a prominent GLP-1 agonist, is marketed under the brand name Wegovy for weight loss, while Ozempic is primarily used for diabetes management but has gained popularity off-label for weight loss.

Both Wegovy and Ozempic work by mimicking incretin hormones that regulate liver sugar production and prolong stomach emptying, leading to prolonged feelings of fullness. Additionally, they impact brain chemicals involved in cravings and overeating, reducing food cravings.

Can Ozempic contribute to eating disorders?

While some individuals may gain weight after discontinuing weight loss medications, often surpassing initial weight levels, the intended duration of use varies among medications. Ozempic, designed for long-term use, may be limited by side effects or costs, potentially resulting in repeated weight fluctuations.

Repetitive weight cycling, characterized by fluctuating weight levels, poses health risks, including increased cardiovascular disease risk and negative self-image, which may trigger unhealthy weight loss attempts.


Some individuals use medications due to a fear of weight gain, despite maintaining a healthy or low weight, or in pursuit of a specific body image, indicating potential signs of an eating disorder.

However, medications like Ozempic may also reduce cravings and overeating, offering potential benefits to individuals with higher weight levels and binge eating tendencies, a topic necessitating further research.

Considerations on different eating disorder types are crucial, given their varied presentations. The main eating disorder classes are:

  • Anorexia nervosa: Characterized by extreme weight gain fears leading to food restriction, excessive exercise, or unsafe weight loss medication use.
  • Bulimia nervosa: Consists of attempts to eliminate calories consumed by vomiting or using laxatives, usually after episodes of binge eating.
  • Binge eating disorder: Most prevalent in the U.S., it involves episodes of excessive eating without subsequent purging.

Why is Ozempic linked to eating disorders?

GLP-1 agonists’ popularity for weight loss stems from their efficacy, supported by widespread social media and television advertisements promoting cosmetic weight loss. This could increase the incidence of eating disorders by reinforcing societal norms that reward thinness.

Should individuals with eating disorders avoid Ozempic?

Weight loss medications are unsuitable for individuals of average or below-average weight, and safety for those above average weight is also questioned.

FDA guidelines authorize GLP-1 agonists like Wegovy and Saxenda for:

  •  Adult individuals whose body mass index (BMI) is 30 or over.
  •  Children aged 12 and above with a BMI at or above the 95th percentile for their age and height.
  •  Adults with a BMI of 27 or higher with accompanying conditions like high blood pressure, high cholesterol, or diabetes.

Treatment decisions should be personalized, with GLP-1 agonists potentially part of a monitored plan for weight loss in individuals with higher weights or binge eating issues. However, caution is advised for others with differing eating disorder types.

Medical guidance is essential when using weight loss medications, which should complement comprehensive strategies for achieving and maintaining a healthy weight. Solutions encompass nutrition, exercise, and mental health support, as very low-calorie diets, weight loss surgeries, or medications alone rarely sustain weight loss.

If you or someone you know is grappling with food-related or weight-related challenges, seeking professional help is crucial, as various treatments can provide support.

In conclusion, while GLP-1 agonists like Ozempic are beneficial for managing diabetes and significant weight loss, their widespread promotion may pose risks, particularly for individuals with or at risk for eating disorders.

365scriptcare is a prescription referral service dedicated to helping customers in the United States to have access to safe, affordable medications. 365scriptcare is a pharmacy affiliate and is not an actual pharmacy. All medications are Canadian sourced. Log onto www.365scriptcare.com to see how you can buy insulin products including Ozempic(semaglutide), Lantus vials along with tablet medications, topical creams, inhalers, cancer meds, pet meds and so much more! All medications are sourced from a reputable Canadian source.

📢 MOUNJARO IS NOW AVAILABLE. It's an alternative to Ozempic. Save up to 70%. Use code 365SCMOUNJARO10OFF for an additional 10% off. Chat now to order!